Cédric BOURA

Professor

Université de Lorraine

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Cédric BOURA is a faculty member at the University of Lorraine in France. His research encompasses tumor biology, especially the interactions of tumor microvesicles and cancer stem cells, as well as novel imaging probes and therapeutic strategies such as photodynamic therapy. Recent articles co-authored by him highlight the roles of neuropilin-1 in brain tumors and the development of dual imaging probes for cancer diagnostics.

Articles (10)

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Katalin Selmeczi

Université de Lorraine

FRANCE

View details

Bertrand Kuhnast

Université Paris-Saclay

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Cédric BOURA

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Cetuximab modifies the release and protein content of tumor microvesicles from head and neck squamous cell carcinoma cells: What are the consequences on endothelial cells?

Cyanine-based [18F]F-C-glycosyl dual imaging probe: synthesis, physico-chemical characterization, in vitro binding evaluation and direct [18F]fluorination

tLyp–1: A peptide suitable to target NRP–1 receptor

Clickable <i>C</i>-Glycosyl Scaffold for the Development of a Dual Fluorescent and [<sup>18</sup>F]fluorinated Cyanine-Containing Probe and Preliminary In Vitro/Vivo Evaluation by Fluorescence Imaging.

NRP1 inhibition modulates radiosensitivity of medulloblastoma by targeting cancer stem cells

Synthesis of anti-proliferative [3.3.0]furofuranone derivatives by lactonization and functionalization of C-glycosyl compounds

Neuropilin-1: A key protein to consider in the progression of pediatric brain tumors

Natural Killer cells and monoclonal antibodies: Two partners for successful antibody dependent cytotoxicity against tumor cells

Synthesis of a DOTA- C -glyco bifunctional chelating agent and preliminary in vitro and in vivo study of [68 Ga]Ga-DOTA- C -glyco-RGD

Design of a targeting and oxygen-independent platform to improve photodynamic therapy: A proof of concept

Collaborators (2)

Katalin Selmeczi

Bertrand Kuhnast

Make your next move.